Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats

Brain Research

Volumn 771, Issue 2, 1997, Pages 271-277

  Wirtshafter, David ^a   Schardt, Greg ^a   Asin, Karen E ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

A 77636; C fos; Calbindin; Dopamine D1 receptor; Dopamine D2 receptor; Immediate early gene; Matrix; Quinpirole; Striosome

Indexed keywords

3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CALBINDIN; DOPAMINE 1 RECEPTOR; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE LOCATION; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DOPAMINE AGONISTS; GENE EXPRESSION; GENES, FOS; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0030782080     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00795-6     Document Type: Article

References (60)

1. Altar C.A., O'Neil S., Walter R.J., Marshall J.F. Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography. Science. 228:1985;597-600.
2. Anderson P.H., Jansen J. Dopamine receptor agonists: selectivity and dopamine receptor efficacy. Eur. J. Pharmacol. 188:1993;189-194.
3. Arnt J., Hyttel J.H., Sanchez C. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioral effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmacol. 213:1992;259-267.
4. Asin K.E., Wirtshafter D. Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression. Eur. J. Pharmacol. 235:1993;167-168.
5. Asin K.E., Wirtshafter D., Nikkel A. Amphetamine induces Fos-like immunoreactivity in the striatum of primates. Brain Res. 719:1996;138-142.
6. B.D. Bennett, J.P. Bolam, Localization of calcium-binding proteins in the neostriatum, in: G. Percheron, J.S. McKenzie, J. Feger (Eds.), The Basal Ganglia IV, Plenum, New York, 1994.
7. Braun A.R., Chase T.N. Obligatory D2/D1 receptor interactions in the generation of dopamine agonist related behaviors. Eur. J. Pharmacol. 131:1986;301-306.
8. Cenci M.A., Campbell K., Wictorin K., Bjorklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci. 4:1992;376-380.
9. Clark D., White F.J. Review: D1 dopamine receptor-the search for a function: a critical evaluation of the D1/D1 dopamine receptor classification and its functional implications. Synapse. 1:1987;347-388.
10. Cook D.F., Wirtshafter D. The D2 agonist quinpirole attenuates striatal C-fos expression induced by serotonergic, opiate and muscarinic agonists. Soc. Neurosci. Abstr. 22:1996;1089.
11. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17:1994;228-233.
12. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods. 29:1989;261-265.
13. Dragunow M., Robertson G.S., Faull R.L.M., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
14. Emson P.C., Augood S.J., Senaris R., Guevara Guzman R., Kishimoto J., Kadowaki K., Norris P.J., Kendrick K.M. Chemical signaling and striatal interneurons. Prog. Brain Res. 99:1993;155-165.
15. Fenelon V.S., Poulain D.A., Theodosis D.T. Oxytocin neuron activation and Fos expression: a quantitative immunocytochemical analysis of the effect of lactation, parturition, osmotic and cardiovascular stimulation. Neuroscience. 53:1993;777-789.
16. Fuxe K., Agnati L.F., Bjelke B., Cintra A., Bortolotti F., Tinner B., Anderson C., Hasselroth U., Steinbush H., Gustafsson J.-A., Benfenatti F. Computer-assisted image analysis techniques allow a characterization of the compartments within the basal ganglia. Focus on functional compartments produced by d-amphetamine activation of the c-fos gene and its relationship to the glucocorticoid receptor. J. Chem. Neuroanat. 4:1991;355-372.
17. Garcia-Munoz M., Young S.J., Groves P.M. Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation. Brain Res. 551:1991;195-206.
18. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. J. Neural Transm. 36(Suppl.):1992;43-50.
19. Gerfen C.R., Baimbridge K.G., Miller J.J. The neostriatal mosaic: compartmental distribution of calcium binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. Natl. Acad. Sci. USA. 82:1985;8780-8784.
20. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
21. Graybiel A.M., Moratalla R. Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. USA. 86:1989;9020-9024.
22. Graybiel A.N., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
23. A.N. Graybiel, C.W. Ragsdale, Biochemical anatomy of the striatum, in: P.C. Emson (Ed.), Chemical Neuroanatomy, Raven Press, New York, 1983.
24. Harrison M.B., Wiley R.G., Wooten G.F. Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res. 596:1992;169-172.
25. Herkenham M., Pert C.B. Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature. 291:1981;415-417.
26. Jackson D.M., Hashizume M. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393. Psychopharmacology. 90:1986;147-149.
27. Jakab R.L., Hazrati L.N., Goldman-Rakic P. Distribution and neurochemical character of substance P receptor (SPR)-immunoreactive striatal neurons of the macaque monkey: accumulation of SP fibers and SPR neurons and dendrites in striocapsules encircling striosomes. J. Comp. Neurol. 369:1996;137-149.
28. Jersch S.M., Cilax B.J., Gutekunst C.Y., Rees H.D., Heilman C.J., Uung K.K.L., Bolam J.P., Ince E., Yi H., Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15:1995;5222-5237.
29. Johansson B., Lindstrom K., Fredholm B.B. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience. 59:1994;837-849.
30. Joyce J.N., Sapp D.W., Marshall J.F. Human striatal dopamine receptors are organized in compartments. Proc. Natl. Acad. Sci. USA. 83:1986;8002-8006.
31. Kebabian J.W., Britton D.R., DeNinno M.P., Perner R., Smith L., Jenner P., Schoenleber R., Williams M.W. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur. J. Pharmacol. 229:1992;203-209.
32. Keefe K., Gerfen C.R. Synergistic response to combined D1- and D2-dopamine receptor stimulation in striatum: immediate early gene response to intrastriatal drug administration. Neuroscience. 66:1995;903-913.
33. LaHoste G.J., Yu J., Marshall J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. USA. 90:1993;7451-7455.
34. LaHoste G.J., Marshall J.F. Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression. Neurosci. Lett. 179:1994;153-156.
35. Larson E.R., Ariano M.A. Dopamine receptor binding on identified striatonigral neurons. Neurosci. Lett. 172:1994;101-106.
36. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNA's in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
37. La Moine C., Normand E., Guitteny A.F., Foque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. USA. 87:1990;230-234.
38. Levey A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., Ciliax B.J. Localization of D1 and D2 dopamine receptors in brain with subtype specific antibodies. Proc. Natl. Acad. Sci. USA. 90:1993;8861-8865.
39. Loopuijt L.D. Distribution of dopamine D-2 receptors in the rat striatal complex and its comparison with acetylcholinesterase. Brain Res. Bull. 22:1989;805-817.
40. Mercuri N., Bernardi G., Calabresi P., Cotungo A., Levi G., Stanzione P. Dopamine decreases cell excitability in rat striatal neurons by pre- and post-synaptic mechanisms. Brain Res. 358:1985;110-121.
41. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc. Natl. Acad. Sci. USA. 89:1992;4270-4274.
42. O'Boyle K.M., Giananopoulos D.E., Brenner M., Waddington J.L. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology. 28:1989;401-405.
43. Paul M.L., Graybiel A.M., David J.C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
44. Rappaport M.S., Sealfon S.C., Prikhozhan A., Huntley G.W., Morrison J.H. Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum. Brain Res. 616:1993;242-250.
45. Roberts R.C., Harrison M.B., Francis S.M.N., Wiley R.G. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons. Exp. Neurol. 124:1993;242-252.
46. Robertson H.A., Paul M.L., Moratalla R., Graybiel A.M. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can. J. Neurol. Sci. 18:1991;380-383.
47. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D1-dopamine agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
48. Robertson G.S., Robertson H.A. D1 and D2 dopamine agonist synergism: separate sites of action? Trends Pharmacol. Sci. 8:1987;295-299.
49. Robertson G.S., Vincent S.R., Fibiger H.C. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res. 523:1990;288-290.
50. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
51. Ruskin D.N., Marshall J.F. Amphetamine and cocaine-induced Fos in the rat striatum depends on D2 dopamine receptor activation. Synapse. 18:1994;233-240.
52. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
53. Settler P.E., Sarau H.M., Zircle C.L., Saunders H.L. The central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50:1978;419-430.
54. Surmeier D.J., Reiner A., Levine M.S., Ariano M.A. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:1993;299-305.
55. Wachtel S.R., Hu X.-T., Galloway M.P., White F.J. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse. 4:1989;327-346.
56. Waddington J.L., O'Boyle K.M. The D-1 dopamine receptor and the search for its functional role: from neurochemistry to behavior. Rev. Neurosci. 1:1987;157-184.
57. Wang J.Q., McGinty J.F. Scopolamine augments c-Fos and ZIF268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience. 72:1996;601-616.
58. Wirtshafter D., Asin K.E. Interactive effects of stimulation of D1 and D2 receptors on Fos like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35:1994;85-91.
59. Wirtshafter D., Asin K.E., Nikkel A. Differential effects of scopolamine and quinpirole on D1 agonist induced striatal c-fos expression in the rat. Soc. Neurosci. Abstr. 21:1995;1425.
60. Wirtshafter D., Asin K.E., Pitzer M.K. Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula. Brain Res. 633:1994;21-26.